Bihua Chen, Director, 10% Owner at BlossomHill Therapeutics, Inc. (BLSM), bought 312,500 shares at $16.00 ($5.0M) on 2026-08-10, disclosed to the SEC on 2026-08-10.
Bihua Chen, a Director and 10% shareholder, purchased $5.0M of stock at $16.00, marking the largest insider purchase in the company's history and signaling strong conviction in the stock's value.
The stock is currently trading at $16.02, essentially flat with the purchase price, and sits 2.76% below its 52-week high of $16.475.
Insider purchased $5.0M, the largest trade in company history, indicating high conviction; track this momentum.
Insufficient data — needs manual review
Nothing distinguishes this filing.
| Filing → |
| AARD | BUY | 2025-02-19 | $3.0M | — | Filing → |
| BIOA | BUY | 2024-10-01 | $8.1M | — | Filing → |
| CRBP | BUY | 2024-03-11 | $46.7M | — | Filing → |